Datos clave para la práctia diaria | 26 AGO 18

Las 10 mejores perlas pulmonares para los médicos de atención primaria

Las perlas basadas en la evidencia en este artículo ayudarán a los médicos a conocer temas importantes de la neumonología y a orientar la decisión de derivar a sus pacientes a un neumonólogo cuando sea necesario
Autor/a: Kwoh EJ; Kaneshiro CY Mayo Clin Proc. 2018; 93(8):1131-1138
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1. Gould MK, Tang T, Liu IL, et al. Recent trends in the identification of incidental pulmonary nodules. Am J Respir Crit Care Med. 2015; 192(10):1208-1214.

2. Fleischner Society guideline update 2017: management of solid

pulmonary nodules. PulmCCM website, https://pulmccm.org/

reviewarticles/fleischner-society-guideline-update-2017/. Accessed

November 21, 2017.

3. Gould MK, Donnington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5, suppl):e93S-e120S.

4. Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low dose CT screening. Lancet Oncol. 2014;15(12):1332-1341.

5. American College of Radiology. Lung-RADS version 1.0 assessment categories. 2014. American College of Radiology website, https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Lung-Rads. Accessed June 2, 2018.

6. Global Initiative for Chronic Obstructive Lung Disease. GOLD 2017 global strategy for the diagnosis, management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease website, http://goldcopd.org/gold-2017-global-strategy-diagnosismanagement-prevention-copd/. Accessed November 15, 2017.

7. Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomized controlled trial. Lancet. 1999; 354(9177):456-460.

8. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003; 124(2):459-467.

9. Leuppi JD, Schuetz P, Bingisser R, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA. 2013; 309(21):2223-2231.

10. Aaron SD, Vandemheen KL, Hebert P, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med. 2003; 348 (26):2618-2625.

11. Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011; 155 (3):179-191.

12. Nici L, Donner C, Wouters E, et al; ATS/ERS Pulmonary Rehabilitation Writing Committee. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006; 173 (12):1390-1413.

13. Carlin BW. Pulmonary rehabilitation and chronic lung disease: opportunities for the respiratory therapist. Respir Care. 2009; 54(8):1091-1099.

14. Holland AE, Mahal A, Hill CH, et al. Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial. Thorax. 2017; 72(1):57-65.

15. National Lung Screening Trial Research Team. Reduced lung cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409.

16. US Preventive Services Task Force. Final recommendation statement: lung cancer; screening. US Preventive Services Task Force website, https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/lung-cancerscreening. Published December 2013. Accessed May 26, 2018.

17. JaklitschMT, Jacobson FL,Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardivasc Surg. 2012; 144(1):33-38.

18. Wood DE, Eapen GA, Ettinger DS, et al. Lung cancer screening. J Natl Compr Canc Netw. 2012;10(2):240-265.

19. Centers for Medicare and Medicaid Services. Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N). CMS.gov website,  http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo. aspx?NCAId¼274. Published 2015.AccessedDecember 22, 2017.

20. Pruett B, Hutchison LC. 2015 Beers criteria nitrofurantoin recommendation. Arkansas Geriatric Education Collaborative, University of Arkansas for Medical Sciences website, http://www.agec.org/2016/05/2015-beers-criteria-nitrofurantoin-recommendation/.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024